{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:20Z","timestamp":1790622080547,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["PID2022-136386OB-I00"],"award-info":[{"award-number":["PID2022-136386OB-I00"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["MCIN\/ AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/ AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013325","name":"Swiss Re Foundation","doi-asserted-by":"publisher","award":["310030-205196"],"award-info":[{"award-number":["310030-205196"]}],"id":[{"id":"10.13039\/100013325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022664","name":"Universidad de Le\u00f3n","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022664","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The TNF family member LIGHT (TNFSF14) binds to two receptors, HVEM (TNFSFR14) and LT\u03b2R (TNFSFR3). HVEM functions as a costimulatory molecule, whereas LT\u03b2R is involved in the development of lymph nodes and ectopic tertiary lymphoid structures at chronic inflammation sites. The classical approach of fusing soluble recombinant proteins to the Fc fragment of IgG resulted in a functionally inactive Ig.mouse (m) LIGHT protein. However, in line with the fact that TNF family members cluster receptors as trimers, addition of a small homotrimeric domain (foldon) N-terminal of mLIGHT produced an Ig.Foldon-mLIGHT protein able to bind and engage HVEM and LT\u03b2R in a cell-based reporter bioassay. In the tumor model of B16.F10 melanoma cells implanted into syngeneic recipients, cells transduced with membrane-bound mLIGHT grew as aggressively as mock-transduced cells, but growth of tumors of B16.F10 cells expressing Ig.Foldon-mLIGHT was delayed and characterized by significant immune infiltration of dendritic cells and cytotoxic cells. This work unveils the potential of active soluble LIGHT, as a single agent, to recruit cytotoxic cells and dendritic cells at the tumor site to inhibit tumor growth. This effect may be further enhanced with immune checkpoint blockade therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key messages<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>The classical approach of fusing soluble recombinant proteins to the Fc fragment of IgG resulted in a functionally inactive Ig.mouse (m) LIGHT (TNFSF14) protein.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The addition of a small homotrimeric domain (foldon) N-terminal of mouse LIGHT produces a proper folded bioactive mouse LIGHT recombinant protein.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Constitutive intratumor expression of secreted Ig-Foldon-LIGHT, but not membrane LIGHT, delays tumor growth.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Tumors secreting LIGHT, as a single agent, promote beneficial anti-tumor responses through the recruitment and infiltration of cytotoxic cells and dendritic cells.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                    <jats:p>The intrinsic source of native soluble LIGHT and LT\u03b11\u03b22 (produced by neutrophils and activated T cells and NK cells) along with the tumor secreting recombinant Ig.Foldon-LIGHT co-stimulate NK and T cells through HVEM and license DC for antigen presentation to promote anti-tumor T cell responses in the tumor draining lymph nodes. Furthermore, native LIGHT produced by neutrophils, NK, and T cells and recombinant LIGHT along with LT\u03b11\u03b22 secreted by recruited B cells (LTi, lymphoid tissue inducer cells) would together activate stromal cells of the tumor microenvironment (TME) through LT\u03b2R (LTo, lymphoid tissue organizing cells) to release chemokines driving endothelial activation and the upregulation of adhesion molecules that in turn would facilitate transmigration of immune cells from the blood vessels to the tumor site. It would also condition myeloid cells expressing LT\u03b2R to secrete cytokines such as TGF-beta that contribute to blood vessel normalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00109-025-02552-x","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:13:56Z","timestamp":1748888036000},"page":"867-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth"],"prefix":"10.1007","volume":"103","author":[{"given":"Maria-Luisa","family":"del Rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar-Mariano","family":"Nuero-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Roncador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garcimart\u00edn-Bailon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Cubria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-5654","authenticated-orcid":false,"given":"Jose-Ignacio","family":"Rodriguez-Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2552_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0968-0004(01)01995-8","volume":"27","author":"JL Bodmer","year":"2002","unstructured":"Bodmer JL, Schneider P, Tschopp J (2002) The molecular architecture of the TNF superfamily. Trends BiochemSci 27:19\u201326","journal-title":"Trends BiochemSci"},{"key":"2552_CR2","first-page":"13964","volume":"281","author":"C Bossen","year":"2006","unstructured":"Bossen C, Ingold K, Tardivel A, Bodmer JL, Gaide O, Hertig S, Ambrose C, Tschopp J, Schneider P (2006) Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. JBiolChem 281:13964\u201313971","journal-title":"JBiolChem"},{"key":"2552_CR3","first-page":"1741","volume":"108","author":"SW Granger","year":"2001","unstructured":"Granger SW, Ware CF (2001) Turning on LIGHT JClinInvest 108:1741\u20131742","journal-title":"Turning on LIGHT JClinInvest"},{"key":"2552_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cytogfr.2008.04.004","volume":"19","author":"P Yu","year":"2008","unstructured":"Yu P, Fu YX (2008) Targeting tumors with LIGHT to generate metastasis-clearing immunity. Cytokine Growth Factor Rev 19:285\u2013294. https:\/\/doi.org\/10.1016\/j.cytogfr.2008.04.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"2552_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1074-7613(00)80455-0","volume":"8","author":"DN Mauri","year":"1998","unstructured":"Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH et al (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21\u201330","journal-title":"Immunity"},{"key":"2552_CR6","doi-asserted-by":"crossref","unstructured":"Del Rio ML, Fernandez-Renedo C, Chaloin O, Scheu S, Pfeffer K, Shintani Y, Perez-Simon JA, Schneider P, Rodriguez-Barbosa JI (2016) Immunotherapeutic targeting of LIGHT\/LTbetaR\/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells. mAbs: 1\u201313","DOI":"10.1080\/19420862.2015.1132130"},{"key":"2552_CR7","doi-asserted-by":"publisher","unstructured":"Ware CF, Croft M, Neil GA (2022) Realigning the LIGHT signaling network to control dysregulated inflammation. The Journal of experimental medicine 219. https:\/\/doi.org\/10.1084\/jem.20220236","DOI":"10.1084\/jem.20220236"},{"key":"2552_CR8","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.4049\/jimmunol.1103698","volume":"188","author":"ML Del Rio","year":"2012","unstructured":"Del Rio ML, Jones ND, Buhler L, Norris P, Shintani Y, Ware CF, Rodriguez-Barbosa JI (2012) Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction. JImmunol 188:4885\u20134896","journal-title":"JImmunol"},{"key":"2552_CR9","doi-asserted-by":"publisher","first-page":"eabm6931","DOI":"10.1126\/sciimmunol.abm6931","volume":"7","author":"GY Seo","year":"2022","unstructured":"Seo GY, Takahashi D, Wang Q, Mikulski Z, Chen A, Chou TF, Marcovecchio P, McArdle S, Sethi A, Shui JW et al (2022) Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection. Science immunology 7:eabm6931. https:\/\/doi.org\/10.1126\/sciimmunol.abm6931","journal-title":"Science immunology"},{"key":"2552_CR10","first-page":"2542","volume":"267","author":"MJ Androlewicz","year":"1992","unstructured":"Androlewicz MJ, Browning JL, Ware CF (1992) Lymphotoxin is expressed as a heteromeric complex with a distinct 33-kDa glycoprotein on the surface of an activated human T cell hybridoma. JBiolChem 267:2542\u20132547","journal-title":"JBiolChem"},{"key":"2552_CR11","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3389\/fimmu.2018.02585","volume":"9","author":"DA Giles","year":"2018","unstructured":"Giles DA, Zahner S, Krause P, Van Der Gracht E, Riffelmacher T, Morris V, Tumanov A, Kronenberg M (2018) The tumor necrosis factor superfamily members TNFSF14 (LIGHT), lymphotoxin beta and lymphotoxin beta receptor interact to regulate intestinal inflammation. Front Immunol 9:2585. https:\/\/doi.org\/10.3389\/fimmu.2018.02585","journal-title":"Front Immunol"},{"key":"2552_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1074-7613(00)80589-0","volume":"9","author":"PD Rennert","year":"1998","unstructured":"Rennert PD, James D, Mackay F, Browning JL, Hochman PS (1998) Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9:71\u201379","journal-title":"Immunity"},{"key":"2552_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nri2832","volume":"10","author":"SA van de Pavert","year":"2010","unstructured":"van de Pavert SA, Mebius RE (2010) New insights into the development of lymphoid tissues. Nat Rev Immunol 10:664\u2013674. https:\/\/doi.org\/10.1038\/nri2832","journal-title":"Nat Rev Immunol"},{"key":"2552_CR14","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1182\/blood-2002-05-1404","volume":"100","author":"G Shi","year":"2002","unstructured":"Shi G, Luo H, Wan X, Salcedo TW, Zhang J, Wu J (2002) Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100:3279\u20133286","journal-title":"Blood"},{"key":"2552_CR15","first-page":"389","volume":"28","author":"TL Murphy","year":"2010","unstructured":"Murphy TL, Murphy KM (2010) Slow down and survive: enigmatic immunoregulation by BTLA and HVEM. AnnuRevImmunol 28:389\u2013411","journal-title":"AnnuRevImmunol"},{"key":"2552_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1084\/jem.20020215","volume":"195","author":"S Scheu","year":"2002","unstructured":"Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. JExpMed 195:1613\u20131624","journal-title":"JExpMed"},{"key":"2552_CR17","first-page":"541","volume":"13","author":"ML Del Rio","year":"2013","unstructured":"Del Rio ML, Schneider P, Fernandez-Renedo C, Perez-Simon JA, Rodriguez-Barbosa JI (2013) LIGHT\/HVEM\/LTbetaR interaction as a target for the modulation of the allogeneic immune response in transplantation. AmJTransplant 13:541\u2013551","journal-title":"AmJTransplant"},{"key":"2552_CR18","doi-asserted-by":"publisher","unstructured":"Yoo KJ, Johannes K, Gonz\u00e1lez LE, Patel A, Shuptrine CW, Opheim Z, Lenz K, Campbell K, Nguyen TA, Miriyala J, et al. (2022) LIGHT (TNFSF14) costimulation enhances myeloid cell activation and antitumor immunity in the setting of PD-1\/PD-L1 and TIGIT checkpoint blockade. Journal of immunology (Baltimore, Md : 1950). https:\/\/doi.org\/10.4049\/jimmunol.2101175","DOI":"10.4049\/jimmunol.2101175"},{"key":"2552_CR19","first-page":"169","volume":"244","author":"MW Steinberg","year":"2011","unstructured":"Steinberg MW, Cheung TC, Ware CF (2011) The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. ImmunolRev 244:169\u2013187","journal-title":"ImmunolRev"},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"E5688","DOI":"10.1073\/pnas.1411072112","volume":"111","author":"TD Holmes","year":"2014","unstructured":"Holmes TD, Wilson EB, Black EV, Benest AV, Vaz C, Tan B, Tanavde VM, Cook GP (2014) Licensed human natural killer cells aid dendritic cell maturation via TNFSF14\/LIGHT. Proc Natl Acad Sci USA 111:E5688-5696. https:\/\/doi.org\/10.1073\/pnas.1411072112","journal-title":"Proc Natl Acad Sci USA"},{"key":"2552_CR21","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.4049\/jimmunol.167.5.2479","volume":"167","author":"Y Morel","year":"2001","unstructured":"Morel Y, Truneh A, Sweet RW, Olive D, Costello RT (2001) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. JImmunol 167:2479\u20132486","journal-title":"JImmunol"},{"key":"2552_CR22","first-page":"232","volume":"229","author":"Y Wang","year":"2009","unstructured":"Wang Y, Zhu M, Miller M, Fu YX (2009) Immunoregulation by tumor necrosis factor superfamily member LIGHT. ImmunolRev 229:232\u2013243","journal-title":"ImmunolRev"},{"key":"2552_CR23","first-page":"1691","volume":"90","author":"T Ito","year":"2011","unstructured":"Ito T, Iwamoto K, Tsuji I, Tsubouchi H, Omae H, Sato T, Ohba H, Kurokawa T, Taniyama Y, Shintani Y (2011) Trimerization of murine TNF ligand family member LIGHT increases the cytotoxic activity against the FM3A mammary carcinoma cell line. ApplMicrobiolBiotechnol 90:1691\u20131699","journal-title":"ApplMicrobiolBiotechnol"},{"key":"2552_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/b978-0-12-801430-1.00005-6","volume":"545","author":"P Schneider","year":"2014","unstructured":"Schneider P, Willen L, Smulski CR (2014) Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members. Methods Enzymol 545:103\u2013125. https:\/\/doi.org\/10.1016\/b978-0-12-801430-1.00005-6","journal-title":"Methods Enzymol"},{"key":"2552_CR25","first-page":"710","volume":"2","author":"X Gao","year":"1995","unstructured":"Gao X, Huang L (1995) Cationic liposome-mediated gene transfer. Gene Ther 2:710\u2013722","journal-title":"Gene Ther"},{"key":"2552_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nprot.2010.43","volume":"5","author":"L Young","year":"2010","unstructured":"Young L, Sung J, Stacey G, Masters JR (2010) Detection of mycoplasma in cell cultures. Nat Protoc 5:929\u2013934. https:\/\/doi.org\/10.1038\/nprot.2010.43","journal-title":"Nat Protoc"},{"key":"2552_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1126\/science.887927","volume":"197","author":"IJ Fidler","year":"1977","unstructured":"Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science (New York, NY) 197:893\u2013895. https:\/\/doi.org\/10.1126\/science.887927","journal-title":"Science (New York, NY)"},{"key":"2552_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4939-3801-8_12","volume":"1458","author":"B Allard","year":"2016","unstructured":"Allard B, Allard D, Stagg J (2016) Methods to evaluate the antitumor activity of immune checkpoint inhibitors in preclinical studies. Methods in molecular biology (Clifton, NJ) 1458:159\u2013177. https:\/\/doi.org\/10.1007\/978-1-4939-3801-8_12","journal-title":"Methods in molecular biology (Clifton, NJ)"},{"key":"2552_CR29","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","volume":"187","author":"P Schneider","year":"1998","unstructured":"Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J (1998) Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187:1205\u20131213. https:\/\/doi.org\/10.1084\/jem.187.8.1205","journal-title":"J Exp Med"},{"key":"2552_CR30","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539\u20133543","journal-title":"Proc Natl Acad Sci USA"},{"key":"2552_CR31","doi-asserted-by":"publisher","first-page":"7747","DOI":"10.1158\/0008-5472.Can-08-3289","volume":"69","author":"MA Curran","year":"2009","unstructured":"Curran MA, Allison JP (2009) Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. Can Res 69:7747\u20137755. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-3289","journal-title":"Can Res"},{"key":"2552_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"A van Elsas","year":"1999","unstructured":"van Elsas A, Hurwitz AA, Allison JP (1999) Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 190:355\u2013366","journal-title":"J Exp Med"},{"key":"2552_CR33","first-page":"1142","volume":"102","author":"Y Zhai","year":"1998","unstructured":"Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M et al (1998) LIGHT, a novel ligand for lymphotoxin beta receptor and TR2\/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. JClinInvest 102:1142\u20131151","journal-title":"JClinInvest"},{"key":"2552_CR34","first-page":"27548","volume":"273","author":"JA Harrop","year":"1998","unstructured":"Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P et al (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM\/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. JBiolChem 273:27548\u201327556","journal-title":"JBiolChem"},{"key":"2552_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1073\/pnas.0711206105","volume":"105","author":"Z Zhou","year":"2008","unstructured":"Zhou Z, Tone Y, Song X, Furuuchi K, Lear JD, Waldmann H, Tone M, Greene MI, Murali R (2008) Structural basis for ligand-mediated mouse GITR activation. Proc Natl Acad Sci USA 105:641\u2013645. https:\/\/doi.org\/10.1073\/pnas.0711206105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2552_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejca.2023.03.040","volume":"187","author":"CW Shuptrine","year":"2023","unstructured":"Shuptrine CW, Perez VM, Selitsky SR, Schreiber TH, Fromm G (2023) Shining a LIGHT on myeloid cell targeted immunotherapy. European journal of cancer (Oxford, England, (1990) 187:147\u2013160. https:\/\/doi.org\/10.1016\/j.ejca.2023.03.040","journal-title":"European journal of cancer (Oxford, England, (1990)"},{"key":"2552_CR37","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fimmu.2020.00922","volume":"11","author":"JG Skeate","year":"2020","unstructured":"Skeate JG, Otsmaa ME, Prins R, Fernandez DJ, Da Silva DM, Kast WM (2020) TNFSF14: LIGHTing the way for effective cancer immunotherapy. Front Immunol 11:922. https:\/\/doi.org\/10.3389\/fimmu.2020.00922","journal-title":"Front Immunol"},{"key":"2552_CR38","doi-asserted-by":"publisher","first-page":"6330","DOI":"10.4049\/jimmunol.167.11.6330","volume":"167","author":"RB Shaikh","year":"2001","unstructured":"Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, Kronenberg M, Cheroutre H, Ware CF (2001) Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. JImmunol 167:6330\u20136337","journal-title":"JImmunol"},{"key":"2552_CR39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ni1029","volume":"5","author":"P Yu","year":"2004","unstructured":"Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YX (2004) Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 5:141\u2013149. https:\/\/doi.org\/10.1038\/ni1029","journal-title":"Nat Immunol"},{"key":"2552_CR40","first-page":"283","volume":"6","author":"K Tamada","year":"2000","unstructured":"Tamada K, Shimozaki K, Chapoval AI, Zhu G, Sica G, Flies D, Boone T, Hsu H, Fu YX, Nagata S et al (2000) Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. NatMed 6:283\u2013289","journal-title":"NatMed"},{"key":"2552_CR41","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.4049\/jimmunol.179.3.1960","volume":"179","author":"P Yu","year":"2007","unstructured":"Yu P, Lee Y, Wang Y, Liu X, Auh S, Gajewski TF, Schreiber H, You Z, Kaynor C, Wang X et al (2007) Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases. Journal of immunology (Baltimore, Md, et al (1950) 179:1960\u20131968. https:\/\/doi.org\/10.4049\/jimmunol.179.3.1960","journal-title":"Journal of immunology (Baltimore, Md, et al (1950)"},{"key":"2552_CR42","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/sj.cgt.7700676","volume":"11","author":"M Hisada","year":"2004","unstructured":"Hisada M, Yoshimoto T, Kamiya S, Magami Y, Miyaji H, Yoneto T, Tamada K, Aoki T, Koyanagi Y, Mizuguchi J (2004) Synergistic antitumor effect by coexpression of chemokine CCL21\/SLC and costimulatory molecule LIGHT. Cancer Gene Ther 11:280\u2013288. https:\/\/doi.org\/10.1038\/sj.cgt.7700676","journal-title":"Cancer Gene Ther"},{"key":"2552_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2010.15","volume":"7","author":"G Hu","year":"2010","unstructured":"Hu G, Liu Y, Li H, Zhao D, Yang L, Shen J, Hong X, Cao X, Wang Q (2010) Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect. Cell Mol Immunol 7:296\u2013305. https:\/\/doi.org\/10.1038\/cmi.2010.15","journal-title":"Cell Mol Immunol"},{"key":"2552_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1158\/2159-8290.cd-13-0985","volume":"4","author":"I Melero","year":"2014","unstructured":"Melero I, Rouzaut A, Motz GT, Coukos G (2014) T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy. Cancer Discov 4:522\u2013526. https:\/\/doi.org\/10.1158\/2159-8290.cd-13-0985","journal-title":"Cancer Discov"},{"key":"2552_CR45","doi-asserted-by":"publisher","unstructured":"Zhang J, Huang D, Saw PE, Song E (2022) Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends in immunology. https:\/\/doi.org\/10.1016\/j.it.2022.04.010","DOI":"10.1016\/j.it.2022.04.010"},{"key":"2552_CR46","doi-asserted-by":"publisher","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI (2021) Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nature reviews Immunology: 1\u201314. https:\/\/doi.org\/10.1038\/s41577-020-00490-y","DOI":"10.1038\/s41577-020-00490-y"},{"key":"2552_CR47","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/eji.200425474","volume":"34","author":"R Ganss","year":"2004","unstructured":"Ganss R, Arnold B, H\u00e4mmerling GJ (2004) Mini-review: overcoming tumor-intrinsic resistance to immune effector function. Eur J Immunol 34:2635\u20132641. https:\/\/doi.org\/10.1002\/eji.200425474","journal-title":"Eur J Immunol"},{"key":"2552_CR48","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1084\/jem.20080099","volume":"205","author":"SA Quezada","year":"2008","unstructured":"Quezada SA, Peggs KS, Simpson TR, Shen Y, Littman DR, Allison JP (2008) Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med 205:2125\u20132138. https:\/\/doi.org\/10.1084\/jem.20080099","journal-title":"J Exp Med"},{"key":"2552_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.719836","volume":"11","author":"T Yang","year":"2021","unstructured":"Yang T, Xiao H, Liu X, Wang Z, Zhang Q, Wei N, Guo X (2021) Vascular normalization: a new window opened for cancer therapies. Front Oncol 11:719836. https:\/\/doi.org\/10.3389\/fonc.2021.719836","journal-title":"Front Oncol"},{"key":"2552_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/path.5080","volume":"245","author":"B He","year":"2018","unstructured":"He B, Jabouille A, Steri V, Johansson-Percival A, Michael IP, Kotamraju VR, Junckerstorff R, Nowak AK, Hamzah J, Lee G et al (2018) Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules. J Pathol 245:209\u2013221. https:\/\/doi.org\/10.1002\/path.5080","journal-title":"J Pathol"},{"key":"2552_CR51","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival A, He B, Li ZJ, Kjell\u00e9n A, Russell K, Li J, Larma I, Ganss R (2017) De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol 18:1207\u20131217. https:\/\/doi.org\/10.1038\/ni.3836","journal-title":"Nat Immunol"},{"issue":"714\u2013724","key":"2552_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.12.013","volume":"30","author":"B He","year":"2020","unstructured":"He B, Johansson-Percival A, Backhouse J, Li J, Lee GYF, Hamzah J, Ganss R (2020) Remodeling of metastatic vasculature reduces lung colonization and sensitizes overt metastases to immunotherapy. Cell Rep 30(714\u2013724):e715. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.013","journal-title":"Cell Rep"},{"key":"2552_CR53","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1182\/blood-2005-08-3485","volume":"107","author":"Z Fan","year":"2006","unstructured":"Fan Z, Yu P, Wang Y, Wang Y, Fu ML, Liu W, Sun Y, Fu YX (2006) NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107:1342\u20131351","journal-title":"Blood"},{"key":"2552_CR54","doi-asserted-by":"publisher","unstructured":"Stringhini M, Mock J, Fontana V, Murer P, Neri D (2021) Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression. mAbs 13: 1868066. https:\/\/doi.org\/10.1080\/19420862.2020.1868066","DOI":"10.1080\/19420862.2020.1868066"},{"key":"2552_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674375","volume":"12","author":"A Johansson-Percival","year":"2021","unstructured":"Johansson-Percival A, Ganss R (2021) Therapeutic induction of tertiary lymphoid structures in cancer through stromal remodeling. Front Immunol 12:674375. https:\/\/doi.org\/10.3389\/fimmu.2021.674375","journal-title":"Front Immunol"},{"key":"2552_CR56","doi-asserted-by":"publisher","unstructured":"Kyrysyuk O, Wucherpfennig KW (2022) Designing cancer immunotherapies that engage T cells and NK cells. Annual review of immunology 41. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-044122","DOI":"10.1146\/annurev-immunol-101921-044122"},{"key":"2552_CR57","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD et al (2018) A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med 24:1178\u20131191. https:\/\/doi.org\/10.1038\/s41591-018-0085-8","journal-title":"Nat Med"},{"key":"2552_CR58","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/0008-5472.Can-11-0431","volume":"71","author":"L Martinet","year":"2011","unstructured":"Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, Rochaix P, Girard JP (2011) Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Can Res 71:5678\u20135687. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-0431","journal-title":"Can Res"},{"key":"2552_CR59","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.imbio.2009.09.008","volume":"215","author":"ML Del Rio","year":"2010","unstructured":"Del Rio ML, Kaye J, Rodriguez-Barbosa JI (2010) Detection of protein on BTLA(low) cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL\/6 and BALB\/c BTLA allelic variants. Immunobiology 215:570\u2013578","journal-title":"Immunobiology"},{"key":"2552_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1084\/jem.150.3.580","volume":"150","author":"JC Unkeless","year":"1979","unstructured":"Unkeless JC (1979) Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. JExpMed 150:580\u2013596","journal-title":"JExpMed"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02552-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:21:46Z","timestamp":1757179306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02552-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02552-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5233856\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.1101\/2024.07.30.605649","asserted-by":"object"}]},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols and experimental designs were authorized and approved by the Animal Welfare Committee of the University of Le\u00f3n and endorsed by Castilla and Leon Regional Government (reference # OEBA- ULE-003\u20132023). Experimental protocols were performed in accordance with the European Guidelines for Animal Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}